Propuesta de un protocolo de valoración neuropsicológica y de calidad de vida en pacientes que han sufrido un infarto maligno de la arteria cerebral media

Malignant middle cerebral artery infarction (MMCAI) refers to an infarction type normally accompanied by massive cerebral edema, and associated with a high mortality rate under conventional therapeutic measures. Both moderate hypothermia and decompressive hemicraniectomy have been shown to significa...

Descripción completa

Detalles Bibliográficos
Autores: Benejam, Bessy, Poca Pastor, María Antonia, Junqué i Plaja, Carme, 1955-, Álvarez Sabin, Jose, Delgado, Pilar, Frascheri, Laura, Martinez Garre, M. C., Sahuquillo, Juan
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2008
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/223074
Acceso en línea:https://hdl.handle.net/2445/223074
Access Level:acceso abierto
Palabra clave:Complicacions (Medicina)
Qualitat de vida
Edema cerebral
Cervell
Infart
Complications (Medicine)
Quality of life
Cerebral edema
Brain
Infarction
Descripción
Sumario:Malignant middle cerebral artery infarction (MMCAI) refers to an infarction type normally accompanied by massive cerebral edema, and associated with a high mortality rate under conventional therapeutic measures. Both moderate hypothermia and decompressive hemicraniectomy have been shown to significantly improve survival rate, although controversy still persists regarding the criteria for the selection of patients that could benefit from this type of treatment, and whether application of these measures is justified given the residual sequelae. In our centre, both measures are being applied simultaneously for the first time in humans. The present work is a literature review on the results of moderate hypothermia application and decompressive surgical techniques in patients suffering from MMCAI. We also introduce our management scheme for handling these patients in our centre, and propose a final result evaluation protocol that is easily applied in a clinical setting. This protocol includes an evaluation of patients with ischemic lesions specific for the right or left hemisphere, and allows for the description of specific neuropsychological sequelae and their repercussions on patients' quality of life.